MedTrace gathered +100 doctors and scientists of nuclear medicine for the company’s symposium on the future of 15O-water

MedTrace gathered +100 doctors and scientists of nuclear medicine for the company’s symposium on the future of 15O-water On October 17, 2022, MedTrace hosted a discussion on the future of 15O-water in conjunction with the 35th annual congress of the European Association of Nuclear Medicine in Barcelona. The event was the first symposium held by […]

ASNC Young Investigator’s Award

Hans receives the Young Investigator’s Award at ASNC Hans Harms, our VP of Software Development, received the Young Investigator’s Award at the ASNC meeting this year. The distinguished prize was awarded for his presentation of the study “Elevated Right-Ventricular Blood Flow is Associated with Diastolic Dysfunction and Adverse Cardiovascular Events, Including Heart Failure with Preserved […]

SNMMI Conference

MedTrace Pharma Exhibits at SNMMI The annual meeting of the Society of Nuclear Medicine and Molecular Imaging (#SNMMI) takes place in Anaheim, California this year on June 22-25. Each year the event attracts more than 5,000 participants from all over the world representing hospitals, academia and industry. MedTrace participates this year with a small booth […]

RESI 3^rd Prize

MedTrace wins 3rd prize at the RESI Innovation Challenge in San Francisco We are excited to announce that MedTrace Pharma took home the 3rd prize in the RESI Innovation Challenge arranged by Life Science Nation with 34 finalists during the JP Morgan conference in San Francisco. More than 150 companies had applied for the Innovation […]